{
  "metadata": {
    "version": "1.0",
    "date": "2026-01-09",
    "author": "Dr Manuel Corpas",
    "title": "Diversity Reporting Audit: UK Cancer Genomics 2020-2025",
    "description": "Systematic audit of ancestry/ethnicity reporting in UK cancer genomics publications"
  },
  "researchQuestion": "What proportion of peer-reviewed UK cancer genomics publications (2020-2025) report participant ancestry or ethnicity, and how is diversity information reported when present?",
  "searchMethodology": {
    "database": "PubMed/MEDLINE",
    "dateExecuted": "2026-01-09",
    "dateRange": "2020-01-01 to 2025-12-31",
    "searchString": "(\"United Kingdom\"[Affiliation] OR \"UK\"[Affiliation] OR \"England\"[Affiliation] OR \"Scotland\"[Affiliation] OR \"Wales\"[Affiliation]) AND (cancer[Title/Abstract] OR neoplasm[Title/Abstract] OR tumour[Title/Abstract] OR tumor[Title/Abstract]) AND (\"whole genome\"[Title/Abstract] OR \"whole exome\"[Title/Abstract] OR WGS[Title/Abstract] OR WES[Title/Abstract] OR GWAS[Title/Abstract] OR \"genome-wide\"[Title/Abstract] OR genomic[Title/Abstract]) AND (\"2020\"[Date - Publication] : \"2025\"[Date - Publication]) AND Journal Article[pt] AND English[lang]",
    "filters": {
      "publicationType": "Journal Article",
      "language": "English",
      "humansMeSH": "Excluded (delayed indexing for recent papers)"
    },
    "totalResults": 3427,
    "goldStandardCapture": {
      "total": 3,
      "captured": 3,
      "rate": 100
    },
    "validationNote": "Humans[MeSH] filter excluded due to delayed indexing of recent papers (PMID 40513586 lacked MeSH indexing)"
  },
  "goldStandardPapers": [
    {
      "pmid": "38200255",
      "title": "Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme",
      "journal": "Nature Medicine",
      "year": 2024,
      "authors": "Sosinsky A, Ambrose J, Cross W, et al.",
      "doi": "10.1038/s41591-023-02682-0",
      "cancerType": "pan-cancer",
      "studyType": "WGS",
      "sampleSize": 13880,
      "dataSource": "Genomics_England",
      "diversityReporting": {
        "reported": "yes",
        "termUsed": "ancestry",
        "categoriesReported": "European, African, South Asian, East Asian, Mixed",
        "ascertainmentMethod": "genetic_inference",
        "fullBreakdown": "yes_counts",
        "europeanPct": 87.2,
        "nonEuropeanPct": 12.8,
        "diversityAsLimitation": "no"
      },
      "notes": "Core Genomics England cancer programme paper. Full ancestry breakdown by genetic inference."
    },
    {
      "pmid": "40513586",
      "title": "Improved recruitment equity in a UK cancer genomic testing programme",
      "journal": "Lancet Oncology",
      "year": 2025,
      "authors": "Evans DG, Woodward ER, Crosbie EJ",
      "doi": "10.1016/S1470-2045(25)00223-2",
      "cancerType": "pan-cancer",
      "studyType": "other",
      "sampleSize": null,
      "dataSource": "Genomics_England",
      "diversityReporting": {
        "reported": "yes",
        "termUsed": "ethnicity",
        "categoriesReported": "Various ethnic groups",
        "ascertainmentMethod": "self_report",
        "fullBreakdown": "mentioned_only",
        "europeanPct": null,
        "nonEuropeanPct": null,
        "diversityAsLimitation": "no"
      },
      "notes": "Commentary on equity improvements. Focus on recruitment strategies for diverse populations."
    },
    {
      "pmid": "40513587",
      "title": "Equity in cancer genomics in the UK: a cross-sectional analysis of a national cancer cohort",
      "journal": "Lancet Oncology",
      "year": 2025,
      "authors": "Nguyen T, Tallman S, Cho Y, Sosinsky A, et al.",
      "doi": "10.1016/S1470-2045(25)00199-8",
      "cancerType": "pan-cancer",
      "studyType": "WGS",
      "sampleSize": 14775,
      "dataSource": "Genomics_England",
      "diversityReporting": {
        "reported": "yes",
        "termUsed": "ancestry",
        "categoriesReported": "European, South Asian, African, East Asian, Mixed",
        "ascertainmentMethod": "genetic_inference",
        "fullBreakdown": "yes_counts",
        "europeanPct": 87.2,
        "nonEuropeanPct": 12.8,
        "diversityAsLimitation": "yes"
      },
      "keyFindings": [
        "4.6% of South Asian patients had potentially pathogenic variants vs 2.2% European",
        "5.3% of African ancestry patients had potentially pathogenic variants",
        "Fewer actionable tumour mutations identified in non-European ancestry patients",
        "Black women 2.7x more likely to be recruited for breast cancer than expected"
      ],
      "notes": "Core equity paper. Directly addresses diversity reporting and outcomes disparities."
    }
  ],
  "auditResults": {
    "status": "in_progress",
    "extractionProgress": {
      "total": 300,
      "completed": 3,
      "percentage": 1
    },
    "preliminaryFindings": {
      "reportingRate": {
        "value": null,
        "ci95Lower": null,
        "ci95Upper": null,
        "note": "To be calculated after full extraction"
      },
      "fullBreakdownRate": {
        "value": null,
        "note": "To be calculated after full extraction"
      }
    },
    "byYear": [
      {"year": 2020, "total": null, "reporting": null, "rate": null},
      {"year": 2021, "total": null, "reporting": null, "rate": null},
      {"year": 2022, "total": null, "reporting": null, "rate": null},
      {"year": 2023, "total": null, "reporting": null, "rate": null},
      {"year": 2024, "total": null, "reporting": null, "rate": null},
      {"year": 2025, "total": null, "reporting": null, "rate": null}
    ],
    "terminologyUsed": {
      "ancestry": null,
      "ethnicity": null,
      "race": null,
      "population": null,
      "mixed": null,
      "notApplicable": null
    },
    "ascertainmentMethods": {
      "selfReport": null,
      "geneticInference": null,
      "ehr": null,
      "notStated": null
    },
    "byCancerType": [],
    "byDataSource": []
  },
  "hypotheses": [
    {
      "id": "h1",
      "statement": "Less than 50% of publications report participant ancestry/ethnicity",
      "target": 50,
      "operator": "less_than",
      "metric": "reportingRate",
      "status": "pending"
    },
    {
      "id": "h2",
      "statement": "Less than 25% provide full quantitative breakdown",
      "target": 25,
      "operator": "less_than",
      "metric": "fullBreakdownRate",
      "status": "pending"
    },
    {
      "id": "h3",
      "statement": "Terminology will be inconsistent across publications",
      "status": "pending"
    },
    {
      "id": "h4",
      "statement": "No significant improvement in reporting rates 2020-2025",
      "status": "pending"
    }
  ],
  "targets": {
    "genomicsEnglandSummit2026": {
      "deadline": "TBD",
      "deliverable": "Abstract submission",
      "status": "in_progress"
    },
    "publication": {
      "target": "Lancet Oncology correspondence or Nature Genetics comment",
      "status": "planned"
    }
  },
  "sources": [
    {
      "label": "PMID 38200255 - 100K Genomes Cancer",
      "url": "https://pubmed.ncbi.nlm.nih.gov/38200255/"
    },
    {
      "label": "PMID 40513586 - Recruitment Equity",
      "url": "https://pubmed.ncbi.nlm.nih.gov/40513586/"
    },
    {
      "label": "PMID 40513587 - Equity in Cancer Genomics UK",
      "url": "https://pubmed.ncbi.nlm.nih.gov/40513587/"
    }
  ]
}
